Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
O95848
UPID:
NUD14_HUMAN
Alternative names:
Nucleoside diphosphate-linked moiety X motif 14
Alternative UPACC:
O95848; Q86SJ8
Background:
Uridine diphosphate glucose pyrophosphatase NUDT14, also known as Nucleoside diphosphate-linked moiety X motif 14, plays a crucial role in cellular metabolism by hydrolyzing UDP-glucose to glucose 1-phosphate and UMP, as well as ADP-ribose to ribose 5-phosphate and AMP. Its primary physiological substrate is UDP-glucose, showcasing limited activity on other substrates like ADP-glucose and GDP-glucose.
Therapeutic significance:
Understanding the role of Uridine diphosphate glucose pyrophosphatase NUDT14 could open doors to potential therapeutic strategies. Its pivotal function in metabolic processes positions it as a key target for drug discovery, aiming to modulate metabolic pathways for therapeutic benefits.